No. 134 / 15 February 2021
To: BUCHAREST STOCK EXCHANGE
FINANCIAL SUPERVISORY AUTHORITY
drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations
Report Date: 15 February 2021
Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")
Unique Registration Code at the National Office of Trade Registry: 8422035
Order number on the Trade Registry: J40/3709/1996
Subscribed and paid-in share capital: 33,217,623 RON
Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category
Significant events to report:
Reporting of transactions with related parties according to art. 923 paragraph (13) of Law no. 24/2017, as amended and supplemented by Law no. 158/2020
In the 12 months period January 2020 - December 2020, MedLife SA concluded / executed transactions with related parties that exceed, cumulatively, 5% of the company’s net assets according to the latest published standalone financial reports of MedLife SA (for 3rd Quarter 2020) amounting to RON 186,923,594, as follows:
· transactions of MedLife SA with Bahtco Invest SA in total amount of RON 21,133,929.
Enclosed to this report we have included the reporting of concluded / executed transactions in the 12 months period January 2020 - December 2020, as well as cumulated mutual debts (balances) as of December 2020.
Chief Executive Officer